Funding Opportunities
Funding Opportunities
- School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes (Posted 1/6/10)
- Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) (Posted 11/4/09)
- Application and Early Stage Development of Emerging Technologies in Cancer Research (R21) (Posted 11/4/09)
- Research on Clinical Decision Making in People with or at Risk for Life-Threatening Illness (R21)
- Exploratory Grants for Behavioral Research in Cancer Control (R21)
- General Funding Opportunities
School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes
NCI is am delighted to announce new obesity policy-related research titled School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes. The PA is issued by NCI, NHLBI, NICHD, OBSSR, and CDC.
|
Announcement
Number |
Issuing
Organization |
Release
Date |
Opening Date
(SF424 Only) |
Expiration
Date |
Activity
Code(s) |
Title
|
|
|
NCI
|
12/10/2009
|
01/05/2010
|
01/08/2013
|
R01
|
School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes (R01)
|
||
|
NCI
|
12/10/2009
|
01/16/2010
|
01/08/2013
|
R21
|
School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes (R21)
|
||
|
NCI
|
12/10/2009
|
01/16/2010
|
01/08/2013
|
R03
|
School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes (R03)
|
Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
|
|||||
Application and Early Stage Development of Emerging Technologies in Cancer Research (R21)
|
|||||
Research on Clinical Decision Making in People with or at Risk for Life-Threatening Illness (R21)
This funding opportunity announcement (FOA) issued by the National Institute of Nursing Research (NINR) and the National Cancer Institute (NCI), National Institutes of Health, seeks to stimulate research on the decision-making processes made by persons at risk for and those faced with life-threatening illness. These illnesses are ones that almost always lead to death in a fairly short period of time if left untreated, but may be chronic – or even cured – if dealt with early in the disease process. An example of a life-threatening illness that may be chronic for some years would be HIV infection when treated. An example of a life-threatening illness that may be cured in its early stages would be breast cancer. Decision-making can occur from the point of adopting preventive behaviors through the end of life. Examples of such decisions could include participating in an HIV vaccine clinical trial, testing for genetic disorder, choosing a treatment intervention vs. watchful waiting (as in early stage prostate cancer), choosing a treatment intervention among several options, joining a therapeutic clinical trial, or making end-of-life care decisions.
Opening Date: May 16
Please click HERE for more information and to apply.
Exploratory Grants for Behavioral Research in Cancer Control (R21)
The purpose of this funding opportunity announcement (FOA) is to encourage exploratory and developmental research projects (R21) grant applications in the cancer control research continuum (i.e., primary prevention to end of life care) from investigators representing a range of behavioral and social science disciplines. With this FOA, the Division of Cancer Control and Population Sciences of the National Cancer Institute (NCI) invites the submission of R21 grant applications that describe research projects that will utilize developmental and exploratory approaches to primary and secondary cancer prevention and control. Research areas may include: cancer health and risk communication; enhancing cancer survivorship; promoting healthy diet and physical activity; prevention and control of tobacco use; interaction between psychosocial and biological mechanisms; cancer screening behaviors; and palliative and end-of-life care.
Studies may focus on: a) assessment (instrumentation methods, measurement development, particularly in new research populations); b) intervention (feasibility of new and innovative approaches, appropriateness for use in populations disproportionately burdened with cancer or in populations involving other clinical, organizational, and community settings); c) dissemination (applications, sustainability); d) surveillance (issues of inclusion of minority populations, data base linkage studies to monitor progress toward cancer prevention and control); and e) biological and psychological influences on cancer and cancer-related behaviors.
To apply for this grant, please click HERE.
General Funding Opportunities
Private Foundation and Corporate Funding Sources
- American Cancer Society
www.cancer.org/docroot/RES/RES_5.asp?sitearea=RES&level=1 - Susan G. Komen Foundation
www.komen.org/grants/default.asp?nodeid=302 - Lance Armstrong Foundation
www.livestrong.org/site/c.jvKZLbMRIsG/b.695469/k.9CE6/Grants__Programs.htm - W.K. Kellogg Foundation
www.wkkf.org/default.aspx?tabid=63&ItemID=6&NID=41&LanguageID=0 - The Mary Kay Ash Charitable Foundation
www.mkacf.org/WomenAndCancer/CancerResearchGrantProgram.aspx - The Nancy R. Gelman Foundation
www.nrgf.org/grants.html